Meeting
2020 ASCO Virtual Scientific Program
Understanding and predicting fatigue, cardiovascular (CV) decline & events after breast cancer treatment (UPBEAT): A prospective multi-center wake forest NCORP research-base study.
Authors
Susan Faye Dent
Duke University School of Medicine, Durham, NC
Susan Faye Dent , Kerryn Reding , Glenn Jay Lesser , Heidi D. Klepin , Lynne I. Wagner , Dalane Kitzman , Peter H. Brubaker , Shannon Mihalko , Nancy E. Avis , Karen Marie Winkfield , Bonnie Ky , Teresa Crotts , Robin Kikuchi , Tonya Calhoun , W. Gregory Hundley
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—Local/Regional/Adjuvant
Track
Breast Cancer
Sub Track
Biologic Correlates
Clinical Trial Registration Number
NCT02791581
Citation
J Clin Oncol 38: 2020 (suppl; abstr TPS602)
DOI
10.1200/JCO.2020.38.15_suppl.TPS602
Abstract #
TPS602
Poster Bd #
94
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
Understanding and predicting fatigue, cardiovascular (CV) decline, and events after breast cancer treatment (UPBEAT): A prospective cardio-oncology study.
First Author: Kerryn Reding
Poster
2024 ASCO Breakthrough
Exploring depression risk among breast cancer survivors: A nationwide cohort study in South Korea.
First Author: Hea Lim Choi
Poster
2024 ASCO Annual Meeting
Knowledge of diagnosis characteristics and treatment received among Mexican breast cancer survivors.
First Author: Citlali Frayde Aguilar
Poster
2023 ASCO Annual Meeting
Oral paclitaxel, carboplatin, and dostarlimab (OPE/Cb/D) without and with trastuzumab in early-stage, high-risk breast cancer: Results from the neoadjuvant I-SPY 2 TRIAL.
First Author: Kay T Yeung